Adams John S, Hewison Martin
Department of Endocrinology, Diabetes and Metabolism, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA.
Nat Clin Pract Endocrinol Metab. 2008 Feb;4(2):80-90. doi: 10.1038/ncpendmet0716.
Knowledge about the ability of vitamin D to function outside its established role in skeletal homeostasis is not a new phenomenon. Nonclassical immunomodulatory and antiproliferative responses triggered by active 1,25-dihydroxyvitamin D were first reported more than a quarter of a century ago. It is only in recent years, however, that there has been a significant improvement in our understanding of how these nonclassical effects of vitamin D can influence the pathophysiology and possible prevention of human disease. Three particular strands of evidence have been prominent: firstly, population studies have revised our interpretation of normal vitamin D status in humans, suggesting, in turn, that vitamin D insufficiency is a clinical problem of global proportions; secondly, epidemiology has linked vitamin D status with disease susceptibility and/or mortality; and, thirdly, expression of the machinery required to synthesize 1,25-dihydroxyvitamin D in normal human tissue seems to be much more widespread than originally thought. Collectively, these observations suggest that nonclassical metabolism and response to vitamin D might have a significant role in human physiology beyond skeletal and calcium homeostasis. Specific examples of this will be detailed in the current Review, with particular emphasis on the immunomodulatory properties of vitamin D.
维生素D在骨骼稳态之外发挥作用的能力并非新现象。25年多前就首次报道了活性1,25 - 二羟基维生素D引发的非经典免疫调节和抗增殖反应。然而,直到近年来,我们对维生素D的这些非经典作用如何影响人类疾病的病理生理学及可能的预防方面的理解才有了显著进展。有三条特别突出的证据:首先,人群研究修正了我们对人类正常维生素D状态的解读,进而表明维生素D不足是一个全球性的临床问题;其次,流行病学已将维生素D状态与疾病易感性和/或死亡率联系起来;第三,在正常人体组织中合成1,25 - 二羟基维生素D所需机制的表达似乎比最初认为的要广泛得多。总体而言,这些观察结果表明,维生素D的非经典代谢和反应可能在人类生理学中发挥着超出骨骼和钙稳态的重要作用。本综述将详细阐述这方面的具体例子,尤其着重于维生素D的免疫调节特性。